Results 41 to 50 of about 38,648 (233)

Clinical Features and Treatment Outcome of a Concurrent Central Retinal Vein Occlusion and Cilioretinal Artery Occlusion

Case Reports in Ophthalmology, 2022
We describe the clinical features and treatment outcome of a patient with combined central retinal vein occlusion and cilioretinal artery occlusion. A 52-year-old female presented to our clinic with decreased vision in the right eye for 4 days.
Alemu Kerie Tesfaw, Nikhil N. Batra, Cong T. Phan   +2 more
doaj   +1 more source

Treating macular edema following RVO [PDF]

, 2014
Retinal vein occlusion (RVO) affects 16 million people worldwide, usually the middle-aged or older. It is caused by thrombosis, the clogging of the retinal veins, which may occur in the four branch veins – branch vein retinal occlusion (BVRO), or in the ...
Hrytsay, T.
core  

Assessment of Ischemic Index in Retinal Vascular Diseases Using Ultra-Wide-Field Fluorescein Angiography:Single Versus Summarized Image [PDF]

, 2016
Background and Objective: To compare a single image with a computer-generated summarized image from the ultra-wide-field fluorescein angiogram (UWFFA) sequence for evaluation of ischemic index (ISI).Materials and Methods: UWFFA sequences from patients ...
Apap, David, Franco-Cardenas, Valentina, Heilweil, Gad, Hubschman, Jean Pierre, Joseph, Anthony, Shah, Sanket U., Trucco, Emanuele, Zutis, Kris   +7 more
core   +2 more sources

Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction

Advanced Healthcare Materials, EarlyView.
Atherosclerosis management is hindered by poor drug targeting and plaque heterogeneity. Nanotechnology overcomes these barriers via three core strategies: (1) target‐engineered nanocarriers that achieve lesion‐specific precision via ligand modification, biomimetic camouflage, stimuli‐responsive release, and self‐propelling nanomotors; (2) catalytic ...
Yuqi Yang, Jingguo Qu, Tonghuan Xiao, Xinyang Han, Michael Tin‐Cheung Ying   +4 more
wiley   +1 more source

Retinal astrocytic hamartoma complicated by branch retinal vein occlusion in a patient with tuberous sclerosis complex

American Journal of Ophthalmology Case Reports, 2023
Purpose: To report a case with branch retinal vein occlusion secondary to a retinal astrocytic hamartoma in a patient with tuberous sclerosis complex.
Pedram Afshar, Haniyeh Zeidabadinejad, Fariba Ghassemi, Hamid Riazi-Esfahani, Elias Khalili Pour   +4 more
doaj   +1 more source

Cavernous sinus thrombosis elicited by a central retinal vein venous stasis retinopathy [PDF]

, 2018
Background: Central retinal vein occlusion is a relatively common retinal disorder in the elderly, and those with cardiovascular or thrombophilic risk factors are at increased risk.
Abdo, German, Pournaras, Constantin, Stangos, Alexandros, Zaninetti, Marc   +3 more
core  

Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion [PDF]

, 2016
No abstract ...
Abdolrahimzadeh, Solmaz, Plateroti, ANDREA MARIA, Plateroti, Pasquale, Scarinci, Fabio   +3 more
core   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

Advanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang, Kejia Li, Ning Wang, Zhen Li, Zhiyong Zhang, Rocky S. Tuan, Yangzi Jiang   +6 more
wiley   +1 more source

STUDIES OF SYSTEMIC AND LOCAL CYTOKINE LEVEL IN RETINAL VEIN OCCLUSION ASSOCIATED WITH ANTIANGIOGENIC THERAPY

Медицинская иммунология, 2018
The paper presents results of studying systemic and local level of cytokines in retinal vein occlusion following antiangiogenic therapy. The study of cytokine concentrations was conducted in the general group of patients, and depended on the type of ...
E. A. Drozdova, D. Yu. Khokhlova, E. A. Mezentseva, K. V. Nikushkina   +3 more
doaj   +1 more source

Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion [PDF]

, 2008
Purpose: To evaluate the effect of intravitreal bevacizumab (Avastin) injections on visual acuity (VA) and foveal retinal thickness in patients with macular oedema secondary to branch retinal vein occlusion.Methods: A prospective, non-comparative ...
Alge, C. S., Burger, J., Haritoglou, Christos, Kampik, Anselm, Kook, Daniel, Kreutzer, Thomas C., Kunze, C., Priglinger, Siegfried, Strauss, R., Wolf, A. H.   +9 more
core   +1 more source